Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are bone-marrow disorders where blood cells are made abnormally. They cause anaemia, bleeding, and frequent infections, and a proportion progress to acute myeloid leukaemia (AML). MDS mainly affects older adults (typically over 60) and is often diagnosed late — a simple blood count usually gives the first clue.

Typical presentation

• Persistent fatigue, breathlessness, pale skin (anaemia).
• Easy bruising, nosebleeds, bleeding gums (low platelets).
• Frequent infections (low white cells).
• Weight loss, night sweats.
• Often found on routine blood test as unexplained cytopenia.

Causes and risks

• Usually no identifiable cause — age is the main factor.
• Previous chemotherapy or radiation for cancer.
• Long exposure to benzene (leather, paint, petrochemical industries).
• Certain inherited bone-marrow disorders.

Diagnosis

• Full blood count, blood film, iron/vitamin B12/folate studies.
• Bone marrow aspiration and biopsy at a haematology department.
• Cytogenetics and molecular testing — guides prognosis and treatment decisions.

Treatment

• Lower-risk MDS: supportive care — blood/platelet transfusions, erythropoiesis-stimulating agents, iron chelation if heavily transfused, treatment of infections, targeted drug therapy in some subtypes.
• Higher-risk MDS: hypomethylating agent class or combination chemotherapy; allogeneic stem-cell transplant is the only potentially curative option for fit patients.
• Regular follow-up with a haematologist.
• Vaccinations, attention to infections — a low-grade fever with neutropenia is an emergency.

Where to seek care in India

• Specialist haematology departments in major government and private cancer centres.
• Ayushman Bharat / PM-JAY and state schemes cover MDS care at empanelled hospitals — social workers can help with scheme enrolment.
• Avoid delays or unproven "blood-building" Ayurvedic preparations — the diagnosis needs a bone marrow test and modern treatment.